Catalog No.
YHA19001
Description
Recombinant Human UBE2C Protein, N-His (YHA19001) is expressed in E. coli and spans Ala2-Pro179. His-tagged for convenient purification and detection, this protein is suitable for ELISA, immunogen, WB and ongoing bioactivity testing. Purity: >90% by SDS-PAGE.
Product Features
- Human UBE2C — Covers amino acid residues Ala2-Pro179 with a predicted molecular weight of 21.83 kDa
- N-His Tag Labeling — Facilitates efficient protein purification, routine detection and experimental operation
- High Purity Quality — Protein purity verified over 90% via SDS-PAGE detection
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Ala2-Pro179
Predicted molecular weight
21.83 kDa
Nature
Recombinant
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
E2 ubiquitin-conjugating enzyme C, UBE2C, Ubiquitin carrier protein C, UbcH10, (E3-independent) E2 ubiquitin-conjugating enzyme C, Ubiquitin-conjugating enzyme E2 C, Ubiquitin-protein ligase C, UBCH10
Background
Recombinant Human UBE2C Protein, N-His (YHA19001) is expressed in E. coli and spans Ala2-Pro179. UBE2C is a core E2 ubiquitin-conjugating enzyme responsible for APC/C-mediated mitotic regulation. It catalyzes K11-linked polyubiquitination and subsequent degradation of cell cycle-related substrates, precisely controlling mitosis progression and genomic integrity. Dysregulation of UBE2C is tightly linked to tumor development, making it a key target for cancer biological research and drug discovery. This high-quality recombinant protein exhibits stable activity and excellent batch reproducibility for ubiquitination mechanism studies and preclinical drug research.
Note
For research use only.



